NEW YORK, Sept. 22 /PRNewswire/ -- The world's largest pharmaceutical and diagnostics manufacturers will present on their most recent data in the application of molecular diagnostics in the discovery and development of new drugs at a comprehensive, industry-wide conference to be held in Princeton, NJ, announces Strategic Research Institute. New technologies and applications in biomarker discovery and translation, gene expression profiling, pharmacogenomics, systems biology, in vivo imaging, and nanotechnology will be presented via keynote and plenary presentations, followed by a panel discussion on the use of molecular imaging agents for disease detection in MRI. Leading clinicians and scientists from Pfizer, Lilly Research Labs, Kereos, Quest Diagnostics, Hoffman La Roche, the National Cancer Institute, and many others will be among the 20+ presenting faculty at the two-day meeting to be held in February, 2005. To request announcement, or for speaking opportunities, please contact Steve J. Kuperberg at firstname.lastname@example.org For sponsorship & exhibition opportunities, please contact Don Buford at email@example.com.
SOURCE Strategic Research Institute